Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001470831-26-000738
Filing Date
2026-07-29
Accepted
2026-07-29 16:18:34
Documents
1
Period of Report
2026-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1785356312.html 4  
1 FORM 4 wk-form4_1785356312.xml 4 4094
  Complete submission text file 0001470831-26-000738.txt   5530
Mailing Address 395 OYSTER POINT BLVD. SUITE 217 SOUTH SAN FRANCISCO CA 94080
Business Address
Bender Jeremy (Reporting) CIK: 0001863107 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 261217808

Mailing Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116 617-468-4219
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)